SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-167398
Filing Date
2023-06-15
Accepted
2023-06-15 07:30:30
Documents
13
Period of Report
2023-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d442378d8k.htm   iXBRL 8-K 30869
2 EX-10.1 d442378dex101.htm EX-10.1 104234
  Complete submission text file 0001193125-23-167398.txt   283999

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mrus-20230614.xsd EX-101.SCH 2841
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrus-20230614_lab.xml EX-101.LAB 17167
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrus-20230614_pre.xml EX-101.PRE 10782
7 EXTRACTED XBRL INSTANCE DOCUMENT d442378d8k_htm.xml XML 3321
Mailing Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM
Business Address YALELAAN 62 3584 CM UTRECHT P7 3584 CM 31 030 253 8800
Merus N.V. (Filer) CIK: 0001651311 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37773 | Film No.: 231015955
SIC: 2834 Pharmaceutical Preparations